Literature DB >> 6658005

Effects of intra-coronary administration of leukotriene D4 in the anaesthetized dog.

L G Letts, D L Newman, S E Greenwald, P J Piper.   

Abstract

The left anterior descending coronary artery in anaesthetized greyhounds was perfused at constant pressure with blood pumped from the carotid artery. Phasic and mean coronary flow, left ventricular pressure, dP/dt, cardiac output, ECG, heart rate and systemic pressure were measured. Leukotriene (LT) D4 was administered into the left anterior descending coronary artery as a bolus injection. LTD4 caused dose-related reductions in coronary flow. Other parameters showed little immediate change although a gradual decrease in left ventricular pressure, dP/dt, cardiac output and systemic pressure occurred after administration of LTD4. Following intracoronary administration of LTD4 small surface haemorrhages were observed over the area perfused. The reduction in coronary flow was not inhibited by indomethacin.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6658005     DOI: 10.1016/0090-6980(83)90194-6

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  6 in total

1.  Effects of a new thromboxane A2-antagonist (ONO-3708) and a new leukotriene-antagonist (ONO-1078) on thromboxane A2 analogue-, leukotriene C4-, and D4-induced regional myocardial blood flow reduction.

Authors:  T Torii; Y Toki; N Hieda; Y Ito; K Okumura; H Hashimoto; T Ito; K Ogawa; T Satake
Journal:  Heart Vessels       Date:  1988       Impact factor: 2.037

2.  Vascular responses to leukotriene B4, C4 and D4 following FPL 55712, indomethacin, saralasin, phentolamine and verapamil in the conscious rat.

Authors:  J Filep; E Földes-Filep; J C Frölich
Journal:  Br J Pharmacol       Date:  1987-02       Impact factor: 8.739

3.  Involvement of thromboxane and leukotriene in arachidonate induced coronary constriction in diabetic rats.

Authors:  Y Takiguchi; K Umemura; H Hashimoto; M Nakashima
Journal:  Diabetologia       Date:  1989-06       Impact factor: 10.122

Review 4.  Leukotriene receptors as potential therapeutic targets.

Authors:  Takehiko Yokomizo; Motonao Nakamura; Takao Shimizu
Journal:  J Clin Invest       Date:  2018-05-14       Impact factor: 14.808

5.  Molsidomine on cardiovascular leukotriene D4 actions.

Authors:  V B Fiedler; T S Abram
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-04       Impact factor: 3.000

6.  Effect of exogenous 5,8,11,14,17-eicosapentaenoic acid on cardiac anaphylaxis.

Authors:  H Juan; B A Peskar; T Simmet
Journal:  Br J Pharmacol       Date:  1987-02       Impact factor: 8.739

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.